Extendicare Inc (EXE.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Extendicare Inc (EXE.TO)

31.81

-0.69 (2.12%)

as of Aug 11, 2026, 2:02:49 pm Market Open.

171 watching

Investor Insights

Aug 10, 2026, 12:00 am

This summary was created by AI, based on 4 opinions in the last 12 months.

Extendicare Inc (EXE-T) is viewed positively by several experts for its strategic position in the healthcare sector, particularly in light of aging demographics. The company's asset-light real estate model and strong management of margins have been highlighted, especially in the context of increased funding from the Ontario government for home healthcare services. While one expert notes it may be undervalued, caution is advised due to a crowded market and potential risks associated with stocks that have experienced rapid price increases. The business model is considered favorable, yet some reviewers emphasize the challenges of growing in a tough environment. Overall, the company's robust market positioning and growth potential are acknowledged, despite nuanced caution regarding its valuation and competition from private equity players.

Consensus

Positive

Valuation

Fair Value

Similar

CSH.UN

DON'T BUY

Model price is around the $7 area. Overvalued.

DON'T BUY

Has been a multi year disappointment. A lot of government regulations. Costs are high.

DON'T BUY

US state legislatures limit their revenues. For demographics, would prefer retirement homes.

BUY

A bit of a value play right now. Has a big asset in some hidden real estate assets. Solid.

WEAK BUY

Bad corporate governance.

DON'T BUY

Growth has not been as great as expected. Demographics for nursing facilities is too far off.

DON'T BUY

Fair market value is $3.

DON'T BUY

Tpp exposed to the swings of the operating income.

Wealthica Track your Stocks in your Watch List

WEAK BUY

Prefers Sunrise instead.

BUY

Good story. Has been in and out of this stock several times. At a good price now.

WEAK BUY

Government issues in US could create severe problems.

STRONG BUY

Very profitable. Should continue to turn around

TOP PICK

Have sold some assets to pay down debt. Trades at a discount to its US peers.

BUY

Has undergone a significant turn around. Refocusing from Florida operations into Ontario.

DON'T BUY

Too overleveraged.

Showing 211 to 225 of 237 entries

Most Recent Experts

Eric Nuttall

Ninepoint Partners

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Jim Lebenthal

Cerity Partners

Karen Firestone, CEO, Aureus Asset Management

Aureus Asset Management

Anastasia Amoroso, Chief investment strategist, iCapital

iCapital

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Extendicare Inc (EXE.TO)